| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |